Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

Clinical trial NCT06979271 · RECRUITING

Trial details

NCT number: NCT06979271
Sponsor: Zhejiang Provincial People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Telitacicept Treatment Compliance Rheumatoid Arthritis

Start date: 2025-06-01
Primary completion: 2026-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.